BRC News

How CAR T-cell therapy transformed Katie’s life with severe lupus.

The research represents a major step towards precision cancer prevention.

It is the first new addition to NHS treatment for ovarian cancer in over 20 years

Join us on Thursday 9 July 2026, 12pm to 4.30pm, at University College Hospital, Euston Road.

Although the trial's main goal was not met, fewer of the most advanced (stage 4) cancers were diagnosed in the later rounds of annual screening among those who had the test.

Researchers estimate more than 5,000 NHS patients a year could avoid chemotherapy.

It follows positive results from BRC-supported research.

Initial results from the research highlight the potential of the therapy as a one-time treatment for high cholesterol, which could remove the need for regular medication.

With around 500,000 bariatric surgeries taking place around the world each year, there is a large need for alternative treatments for this group.

The day recognises and thanks everyone involved in research, including participants and research teams.

There is an urgent need for new therapeutic approaches.

The study reinforces the importance of involving people from diverse ethnic backgrounds in research.

The principles cover the safe use of patient data and transparency about data use in research.

The non-commercial trial supported by our NIHR BRC aims to treat at least 12 patients over the next two years.

Patients on the BRC-supported trial were treated with a short course immunotherapy before surgery instead of post-op chemotherapy.